LOXL1 high expression group was characterized by escalated infiltration of immunosuppressive components, while LOXL1 low expression group was linked to a richer infiltration of anti-tumor immune cell signatures, including CD8 + T cells and interferon-γ signatures (Fig. 5B). This evidence concerns the gene CD8A and neoplasm.